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Abstract  
Objective: To examine the variability of hospital performance within and across countries, 
using 30-day acute myocardial infarction (AMI) mortality, and to study the impact of hospital 
characteristics on performance. 
Study setting: Hospital-level adjusted risk standardized mortality rates (RSMR) and hospital 
characteristics were collected from 10 OECD countries 10 and two collaborating countries 
including 1,163 hospitals. Rates were based on AMI admissions between 2013 and 2015.  
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Study design: Associations between RSMR and hospital characteristics were studied using 
univariate and multivariate linear regressions. Clusters of hospitals were created using 
hierarchical clustering and mortality compared using linear regression.  
Findings: Wide variation between countries was found for RSMR and hospital 
characteristics. Regression models showed large country effects. A high volume of AMI 
admission was associated with lower RSMR in a model using a restricted number of hospital 
characteristics (-0.83, p < 0.001) but not in a model using all characteristics (-1.03, p=0.06). 
Analysis within countries supported this association. Hospital clusters showed clear 
differences in characteristic distributions but no difference in RSMR.  
Conclusions: The effect of volume may support policies toward a concentration of services 
within the hospital sector. The effect of other hospital characteristics was inconclusive and 
suggests the importance of system-wide characteristics or pathways of care (i.e. timeliness 
and nature of initial response and during transportation to a hospital, transfers between 
hospitals, post-discharge organization) in explaining variation.  
Highlights: 
 Wide variation between countries was found for RSMR and hospital characteristics. 
 High volume of AMI admission was associated with lower RSMR. 
 Within countries analysis supported this association. 
 Hospital clusters showed no significant difference in RSMR. 
Keywords: hospital performance; international comparison; AMI mortality; hospital 
characteristics 
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Introduction 
Hospital performance is a key aspect of health systems and an important target in national 
efforts to improve overall system performance [1,2]. The Organization for Economic 
Cooperation and Development (OECD) currently publishes a number of hospital 
performance-related indicators on the national level. These indicators are used by member 
countries for a range of policy objectives including: public accountability and transparency, 
benchmarking and quality improvement, standard setting and compliance, and governance 
and management performance assessment [3,4]. 
The 30-day mortality rate for acute myocardial infarction (AMI) is one key OECD hospital 
performance measure used to understand performance across countries. Overall rates of 30-
day AMI mortality have decreased in recent years in many countries but some large variation 
continues to exist at the national and hospital-level [5]. Indeed, health care quality indicators 
at a national level can mask important within-country variations in hospital performance [6]. 
Understanding hospital-level variation including its main drivers is important to implement 
policy responses to reduce variation and in improving performance.  
A number of national studies have examined hospital variation in 30-day AMI mortality 
through the role of various hospital characteristics. Hospital size, academic status, ownership 
type, and location among other characteristics have been shown to be important factors in 
explaining variation in some studies. [7–10]. Debate remains however about the impact of 
these characteristics. For example Bradley et al. found significant associations between 30-
day AMI mortality and academic status, number of hospital beds, AMI volume, cardiac 
facilities available, urban/rural location, geographic region, ownership type, and the 
socioeconomic status (SES) profile of patients. On the other hand, Krumholtz et al. found that 
hospital characteristics such as number of beds, ownership, academic status, and technical 
capacity were not key drivers of performance variation [11]. 
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Interest has grown in recent years in moving beyond national studies to understanding 
hospital performance variation internationally. These data may provide additional insight into 
within country variations and allow for international hospital performance benchmarking as 
well as cross-country comparisons and learning opportunities. Significant methodological and 
scientific progress has been made in this area internationally through European studies of 
hospital performance and efficiency including the European Hospital outcomes, Performance 
and Efficiency project (http://www.eurohope.info/) and the European Collaboration for 
Healthcare Optimisation project (http://echo-health.eu/). Both studies rely on the collection of 
patient level data to undertake international comparisons and have developed methodologies 
for internationally comparable indicators of hospital performance and efficiency including 30-
day AMI mortality. Studies in European countries report differences in AMI outcome across 
countries and a relationship between volume and mortality [12,13]. However, these studies 
focus on one continent and on factor at a time.  
Building on this international work, the OECD launched the hospital performance project in 
2015 in order to better understand hospital performance across OECD countries and to increase 
international comparisons. This work mirrors much of the methodological foundations of 
ECHO and EuroHOPE, particularly given the lead researchers of these projects were members 
of the methodology expert group guiding the work. Key improvements include: providing a 
more feasible way of routinely collecting data from a wide range of countries without 
establishing data exchange agreements such as in the ECHO project, utilizing linked data to 
account for hospital transfers and deaths outside of the hospital like the ECHO project, and 
extending the scope of the project beyond Europe to other OECD countries. This project 
collected risk adjusted hospital-level 30-day AMI mortality at the hospital level along with 
hospital characteristics from participating countries. Participation in the project was voluntary 
and solicited from all OECD countries as well as from selected partner countries including 
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Malta and Singapore. Project aims included broadening the availability of internationally 
comparable data on hospital performance and providing opportunities for performance 
benchmarking. The study also sought to better understand the hospital-level factors related to 
AMI mortality variability including the role of: hospital ownership, technical capacity, location, 
expertise, and volume. To our knowledge, this study is the first to bring together hospital-level 
data from multiple continents.  
Material and methods 
Risk standardized mortality rates (RSMR) for 30-day AMI1 mortality were computed from 
patient level data within each participating country and provided to the OECD at the hospital 
level. Data was received from 10 OECD countries including: Canada, Denmark, Finland, 
Israel, Italy, Korea, Latvia, Norway, Slovenia, and Sweden as well as two collaborating 
countries including Malta and Singapore. Rates were based on patient data aggregated across 
the years 2013-2015 and adjusted for age, sex, existence of complicating conditions (co-
morbidity) and previous AMI-admission and were calculated from national hospital 
administrative databases.   
A linked-record approach to calculating RSMR was used within each country. This approach 
requires that a unique patient identifier be available for use across multiple administrative 
databases to allow for the linkage of hospital admissions within and across hospitals as well as 
to death registries. Using this approach, 30-day mortality was calculated as the number of 
patients dying within 30 days of admission to hospital for an AMI divided by the total number 
of patients admitted to the hospital for an AMI. In the case of a patient transferred to a second 
hospital following an initial AMI admission, death was attributed to the first hospital where 
                                                          
1 AMI was defined using ICD-9-CM codes '4100', '4101', '4102', '4103', '4104', '4105', '4106', '4107', '4108', 
'4109' or ICD-10-WHO codes 'I210', 'I211', 'I212', 'I213', 'I214', 'I219', 'I220', 'I221', 'I228', 'I229'. Countries using 
coding systems other than ICD-9-CM or ICD-10-WHO were asked to use equivalent codes in their local system. 
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admission occurred. In the case of multiple eligible admissions for a single patient, only the 
most recent admission was used for calculation purposes. Canadian hospital data was not fully 
linked to death registries meaning some deaths occurring outside of the hospital may not have 
been included in calculations. 
A number of hospital characteristics were collected directly at the hospital level including: 
hospital ownership (government-owned/non-government owned), presence of a catheter lab 
(Y/N), location (urban/rural), academic status (Y/N) and the volume of AMI admissions over 
the observation period. Given variable data availability and definitions across participating 
countries, these hospital characteristics, defined as dichotomous variables, were selected as 
the most relevant and comparable for the purposes of this study. 
A binary “high AMI” variable was created which identified the 25% of hospitals with the 
highest AMI caseload in each country as “high” regardless of the relative position with other 
countries. This definition was selected given the large variation of AMI volume between 
countries and based on the hypothesis that a hospital in a country with lower overall AMI 
volume per hospital might still acquire relatively more experience and expertise in treating 
patients than other lower-volume hospitals within the country. Based on this definition, a 
“high AMI” hospital in a country with low overall AMI admissions may have fewer AMI 
cases over the observation period than a non-“high AMI” hospital in a country with higher 
overall AMI admissions. This construction avoided attributing “high AMI” only to hospital in 
countries with higher overall AMI admissions and turning this variable into a mere proxy for 
a country effect. 
783 hospitals with less than 50 AMI admissions over the observation period were excluded 
from analyses due to the extreme variability of RSMR in these hospitals. This threshold was 
chosen after sensitivity testing and consultation of the international expert group of the 
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hospital performance project. Most of the excluded hospitals (768 (98%) were located in 
Canada, Italy or Korea), the remaining being located in Denmark, Latvia, Norway or 
Slovenia. Within countries, excluded hospitals represented between 7.4% and 50.3% (28.9% 
on average) of the initial sample. The final sample was composed of 1,163 hospitals. 
International data collection was performed using SAS software. Standard SAS code was 
provided to participating countries by the OECD and run on national hospital administrative 
data.  
Data analysis 
Associations between RSMR and the hospital characteristics were first evaluated 
independently using univariate regression for each hospital characteristic.  
Next, two multiple linear regression models were used. The first model (named “all 
characteristics”) used a country indicator and all five hospital characteristics as explanatory 
variables, without interaction terms 2. The second model (named “restricted characteristics”) 
included only the country indicator, high AMI volume, academic status and presence of a 
catheterization laboratory, with the 2-by-2 and triple interaction terms between the binary 
characteristics3. The urban/rural and government owned characteristics were dropped from the 
second model due to heterogeneous definitions across countries and a general lack of non-
government owned hospitals in the sample.  
                                                          
2 RSMR =  𝛽0 + 𝛽1 ∗ (High volume of AMI = "𝑌𝑒𝑠") + 𝛽2 ∗ (Catheterization laboratory = "𝑌𝑒𝑠") + 𝛽3 ∗
(Academic = "𝑌𝑒𝑠") + 𝛽4 ∗ (Urban = "𝑌𝑒𝑠") + 𝛽5 ∗ (Government owned = "𝑌𝑒𝑠") + ∑ 𝛽6𝑗 ∗
(Country = Country𝑗) +  𝜀 
3 RSMR =  𝛽0 + 𝛽1 ∗ (High volume of AMI = "𝑌𝑒𝑠") + 𝛽2 ∗ (Catheterization laboratory = "𝑌𝑒𝑠") + 𝛽3 ∗
(Academic = "𝑌𝑒𝑠") + ∑ 𝛽4𝑗 ∗ (Country = Country𝑗) + 𝛾1 ∗ (High volume of AMI = "𝑌𝑒𝑠") ∗
(Catheterization laboratory = "𝑌𝑒𝑠")  + 𝛾2 ∗ (High volume of AMI = "𝑌𝑒𝑠") ∗ (Academic = "𝑌𝑒𝑠") + 𝛾3 ∗
(Catheterization laboratory = "𝑌𝑒𝑠") ∗ (Academic = "𝑌𝑒𝑠") + 𝛾4 ∗ (High volume of AMI = "𝑌𝑒𝑠") ∗
(Catheterization laboratory = "𝑌𝑒𝑠") ∗ (Academic = "𝑌𝑒𝑠") + 𝜀 
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Finally, in order to investigate the country-specific differences and further examine the effect 
of hospital characteristics, the second model (without country effects) was also run on all 
countries separately.  
A sensitivity analysis on the coding of the AMI admission volume was completed by using 
the same regression models with AMI volume as a continuous variable, in global quartiles and 
by-country quartiles. Another sensitivity analysis was completed using hospital beds density 
terciles of countries instead of individual countries effects. 
Multicollinearity was assessed using variance inflation factors (VIF). 
To test the relationship of different hospital types with AMI mortality, clusters of hospitals 
based on distributions of the five hospital characteristics were created using hierarchical 
agglomerative clustering (HC). This unsupervised clustering method creates a hierarchy of 
clusters step by step, merging the closest clusters according to a given distance between 
categories at each step (more mathematical details are provided in supplementary material 1). 
Since the characteristics are both nominal and quantitative, the Gower distance was used to 
compute the dissimilarity matrix of the hospitals [14]. Mortality differences between clusters 
were tested using linear regression.  
Data analysis was performed using the R 3.4.1 software [15]. The risk alpha was set at 5% to 
assess the significance of the differences and results. 
Results 
Descriptive statistics 
Average RSMR was 9.06 per 100 AMI admissions across all countries (standard deviation: 
3.20). Country level average RSMR ranged from 8.03 in Canada to 18.23 in Malta. By 
country RSMR distribution is shown in Figure 1. RSMR of hospitals with fewer than 50 AMI 
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admissions (excluded from main analysis) ranged from 0 to 447.11, with an average of 17.29 
and a standard deviation of 36.73.  
(include Figure 1 here) 
Results for hospital characteristics showed wide variability across countries (Table 1). The 
proportion of hospitals with a catheterization laboratory varied from 12% (Norway) to 100% 
(Finland and Korea), the proportion of urban hospitals varied from 9% (Sweden) to 100% 
(Malta, Singapore, Slovenia), and the proportion of academic hospitals ranged from 8% 
(Italy) to 100% (Israel). Only the proportion of government owned hospitals was consistently 
high across countries in the studied sample (93% overall, from 42% (Israel) to 100% 
(Denmark, Finland, Latvia, Malta, Singapore, Slovenia)). 
(include Table 1 here) 
Associations between RSMR and hospital characteristics 
In univariate analysis, only high volume of AMI (-0.81, 95%CI (-1.23, -0.39), p < 0.001) had 
a significant negative association with RSMR (supplementary material 2). When hospital 
characteristics were introduced in the first multivariate model (all variables), a significant 
association with RSMR was observed for high volume of AMI (-0.83, 95%CI (-1.30, -0.36), p 
< 0.001) and government ownership (1.08, 95%CI (0.31, 1.85), p = 0.006). In the second 
model (restricted characteristics), only the high volume of AMI was borderline significant (-
1.03, 95%CI (-2.13, 0.06), p = 0.06). Other characteristics (presence of a catheter lab, 
location, and academic status) had no significant effect in either model, with particularly high 
associated p-values. Interaction terms were also not significant in model 2 (Table 2). 
(include Table 2 here) 
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Results for the sensitivity analyses on the AMI variable are available in supplementary 
material 3. Using AMI volume as a continuous variable, in global quartiles or by-country 
quartiles gave similar results for the model with all characteristics included. For the model 
with restricted characteristics, AMI volume had a significant effect (instead of borderline 
significant) in all sensitivity analyses. Catheterization laboratory and its interaction with AMI 
volume had a significant effect when AMI volume was used as a continuous variable. 
Results for the sensitivity analyses using hospital beds density terciles are available in 
supplementary material 4. The effects of AMI volume, academic status, location and 
government ownership were similar to those already presented in both models. The presence 
of a catheterization laboratory was borderline significant in the model with restricted 
characteristic. Hospital beds density terciles were strongly significant in both models, with a 
positive association with RSMR for countries with a higher hospital bed density compared to 
countries with the lowest hospital beds density. 
Assessment of country effects 
In univariate analysis, country effects were significantly associated with RSMR (global p 
<0.001) (supplementary material 2). In multivariate analyses, with the exception of Canada, 
most countries showed significant positive effects on RSMR when compared to Italy in both 
models (Italy was used as reference since it was the country with the largest number of 
hospitals in the sample). The impact of the country effect on explaining variation across the 
global dataset was large. Both models had an adjusted-R² of 0.22, explained principally by the 
country effect (the same models without country effect had an adjusted-R² of 0.02). 
Within country regressions analyses rarely showed significant results due in part to small 
sample sizes. However, in most countries, both the high volume of AMI and the presence of a 
catheter lab showed a non-significant negative relationship with RSMR (Table 3).  
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(include Table 3 here) 
Hospital clusters 
We created five hospital clusters by applying HC on data (Table 4). Cluster 1 was composed 
of 470 hospitals with a small volume of AMI admissions (fewer than 235 AMI admissions on 
average over the observation period). These hospitals were non-academic, did not have 
catheterization laboratories, and were mostly government owned and rural. Cluster 2 was 
composed of 101 hospitals with characteristics similar to those of cluster 1 (small volume of 
AMI admissions -cluster average: 373-, non-academic, without catheterization laboratories, 
government owned) but with urban rather than rural hospitals. Cluster 3 was composed of 235 
hospitals with the second highest volume of AMI admissions (cluster average: 787), which 
were government owned, rural, with catheterization laboratories and mostly non-academic. 
This cluster differs from cluster 1 and 2 by the presence of a catheterization laboratory as well 
as a higher volume of AMI admission. Cluster 4 was composed of 190 hospitals with a 
median volume of AMI admissions (cluster average: 577), a non-academic status, high 
presence of catheterization laboratories, and which were mostly urban and government owned 
(although the proportion of private hospitals is the highest in this cluster). This cluster differs 
from cluster 3 by its distribution of urban and private hospitals. Cluster 5 was composed of 
167 hospitals with the highest volumes of AMI admissions, high academic status, and high 
presence of catheterization laboratories. These hospitals were also mostly government owned 
and urban. 
(include Table 4 and Figure 2 here) 
Despite strong differences in hospital cluster differentiation based on hospital characteristics, 
our analysis found no evidence for an association between our hospital clusters and RSMR 
(Table 4 and Figure 2).  
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Discussion  
This study shows important variations of AMI 30-day RSMR at the hospital level both 
between and within countries. These analyses were made possible through an international 
data collection with unprecedented scope and coverage. Overall, specific country effects 
explain a large part of the variability and a high AMI volume appears to be associated with 
lower mortality rates. The effect of the presence of a catheterization laboratory was 
inconclusive and no association was found between the academic status or the urban/rural 
location of hospitals and RSMR.  
Our results are partly in line with other published studies. In 2010, Bradley et al. showed a 
lower AMI 30-day RSMR among academic and urban hospitals with a greater volume of 
AMI admission in the US, and in hospitals with open heart surgery capacity compared to 
hospitals with only catheterization laboratory or nothing [7]. Other studies have found an 
effect of greater volume in lowering RSMR but sometimes with a “volume threshold” after 
which increased volume did not result in lower mortality [9,10,16]. Analysis of our hospital 
data by volume strata suggested a similar volume threshold but differences between groups 
were non-significant. Other authors found reduced mortality among academic hospitals which 
was not reflected in our results [8,11]. Some questions remain about the effect of the 
ownership status as some studies found a reduced mortality in public hospitals [11] while 
others found increased mortality [10]. Our sample did not allow for this relationship to be 
sufficiently tested. 
The negative correlation between AMI volume and RSMR may be explained in several ways. 
Hospitals with more AMI cases may have a staff with better experience and knowledge of 
good practices as well as specific and well-established organizational processes (both within 
the hospital and with other health professionals in the post-hospitalization phase) for AMI 
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patients, which could improve survival [13]. Previous research has found a similar 
relationship between the number of cardiovascular procedures performed by a physician and 
short-term mortality [17], and between volume and surgical mortality [18,19]. Although small 
hospitals were not included in this study, their high average RSMR adds another indication of 
a volume effect. Our definition of high AMI may also play a role in interpreting this 
relationship. We selected the top volume hospital in each country regardless of the overall 
distribution. The relationship between high AMI and RSMR may therefore suggest a 
centralization of expertise and resources within each country regardless of the relative size 
internationally. The relationship between high AMI volume and lower RSMR within 
countries, while not statistically significant, may support this idea however this hypothesis 
remains speculative.  
In multivariate models, presence of a catheterization laboratory showed no significant 
relationship with RSMR despite representing more advanced care capacity. Hospitals with a 
catheterization laboratory may admit more complex and/or severe AMI cases, which may 
explain some increase in mortality. However, most within-country analyses show a negative, 
although non-significant, effect of the catheterization laboratory. Taking into account 
additional characteristics (for instance ST-segment elevation myocardial infarction (STEMI) 
status) may help to explain these results. 
The clusters constructed by hierarchical clustering are strongly differentiated on hospital 
characteristics; however, the absence of significant differences on mortality rates shows they 
are not sufficient to explain RSMR variations. Other classification methods, or other sets of 
characteristics, may give different results. Some studies have used hospital clusters as an 
explanatory variable for AMI RMSR, such as Bertomeu et al in Spain, who show a significant 
association between mortality and hospital clusters defined by the Spanish Ministry of Health 
and based on size, equipment, teaching activities, and complexity of care [20]. 
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The construction of the RSMR indicator may play a role in our findings. Death in our 
calculation is attributed to the first hospital of admission even if a patient was transferred to 
and died in another hospital. This may have a variable effect on hospital mortality rates based 
on the relative proportion of transfer patients and the mortality rates of these patients [21,22]. 
Transfers within countries and care pathways can be dramatically different between countries 
which may affect RSMR and the relationship with hospital characteristics [23]. For example 
Norway has implemented a policy of care centralization (i.e. a small number of “reference 
centers” where patients are directed by “prehospital” services) in recent years which is 
reflected in the relatively low number of hospitals with catheter labs in our sample[24]. Other 
calculations for AMI-mortality exist which take a different approach to death attribution [12].  
Our results showed a wide distribution of hospital characteristics which may be indicative of 
real differences across countries including aspects such as hospital financing, organization, 
and structure. Characteristic distributions may also be affected by the nature of data available 
to countries. For example, the high proportion of government owned hospitals in our dataset 
may reflect the greater availability of these data rather than a truly higher proportion across 
countries. This heterogeneity between countries could impact analyses in the sense that they 
no longer asses the characteristic’s true effect, but a mixture between the true effect and the 
country effect. Adding country or system-level characteristics to future analyses could help 
address this issue.  
The relatively small impact of hospital characteristics on mortality may highlight the 
importance of other within-hospital variables, such as organizational culture (treatment 
protocols, team organization) or team experience (generally and/or specifically for the 
catheterization laboratory) found to be important in other studies in addition to the physician 
experience [25,26]. This may also highlight the importance of some system level 
characteristics such as systems of transfers and care centralization. Initial research into these 
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system level characteristics was carried out in 2017 by Moger et al. Researchers examined the 
differences in acute coronary syndrome mortality between Norway and Finland which have 
similar populations but different structures of care (decentralized in Finland with reduced 
emergency preparedness, centralized in Norway with large PCI departments). Results did not 
show a strong effect of organization variables such as distance to hospital, PCI hospital 
volume, and time to treatment among others [27]. 
To our knowledge, this is the first international analysis of the impact of hospital 
characteristics on AMI mortality rates of this scope and scale. However, our “global” results 
have to be qualified by the county-specific results, which show some heterogeneity between 
countries and are reflected in the large country effects in our models.  
Our study has several limitations. Firstly, RSMR rates were not adjusted for STEMI status 
which is related to AMI treatment and the risk of mortality. This was due to highly variable 
STEMI coding quality and completeness across countries making adjustment unfeasible. 
Differences in secondary diagnosis coding depth were highly variable across countries which 
may also have an impact on adjustment by co-morbidity. Similarly, no complete information 
about timing of procedure was available which has been shown to have a large impact on 
survival [28]. On the country level, no information about the countries health systems, such as 
referral process, was available either. This information may help understand between-
countries differences. Inclusion of such data into subsequent analyses could help to address 
these issues.  
Secondly, due to a lack of precision of certain hospital characteristics, data used in analyses 
may have been affected by different interpretations between countries. For example, no 
precise definition was provided for urban and rural categories and local country definitions 
were heterogeneous. 
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Thirdly, due to data available in countries, our sample is mainly composed of government 
owned hospitals and may not be representative of all hospitals in a country.  
Finally, small hospitals were excluded from analyses, although they represented about 40% of 
the initial sample and up to 50% of hospitals within individual countries. Additional work is 
planned to take into account these hospitals and their specificities. 
Conclusion 
AMI admission volume appears to have an important effect on the AMI RSMR, globally and 
in most of the countries studied. Rather than indicating absolute volume however, the 
definition of high AMI volume used in this study may suggest a link with the centralization of 
expertise and resources within each country.  These results may support efforts for a 
concentration of services in the hospital sector however, as shown in other studies, further 
study is needed to better understand the complexities of this relationship. The effect of other 
hospital characteristics was less clear. Future research may be enhanced by evaluating 
characteristics of the health system and health care organization including assessing the whole 
pathway of AMI care.  
Finally, more availability and comparability of data across countries, including patient and 
system level characteristics as well as medical practice recording, may allow a deeper 
understanding of the drivers of performance.  
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Figures captions: 
Figure 1.  
 
Title: RSMR distribution, by country. 
Legend: For a given boxplot, the bar in the middle of the box represents the median value. The top and bottom 
of the box represent the limits of the first (Q1) and third quartile (Q3). The whole box therefore shows the 
interquartile range (IQR). The lines (whiskers) outside of the box range from Q1-1.5IQR to Q3+1.5IQR. The 
dots are “outliers”, values outside of this range. 
Note: Canadian hospital data were not fully linked to death registries potentially lowering RSMR 
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Figure 2.  
 
Title: RSMR distribution, by clusters. 
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Table 1. Distribution of the hospitals characteristics, overall and by country. 
Country N 
Urban (n(%)) 
Catheterization laboratory 
(n(%)) 
Government owned (n(%)) Academic hospital (n(%)) 
AMI 
volume 
(median 
(IQR)) 
Yes No NA Yes No NA Yes No NA Yes No NA 
Canada 301 
116 
(38.5%) 
177 
(58.8%) 
8 
(2.7%) 
53 
(17.6%) 
240 
(79.7%) 
8 
(2.7%) 
293 
(97.3%) 
0 
(0.0%) 
8 
(2.7%) 
44 
(14.6%) 
249 
(82.7%) 
8 
(2.7%) 
257.0 
(413.0) 
Denmark 26 
18 
(69.2%) 
8 
(30.8%) 
0 
(0.0%) 
17 
(65.4%) 
9 
(34.6%) 
0 
(0.0%) 
26 
(100%) 
0 
(0.0%) 
0 
(0.0%) 
5 
(19.2%) 
21 
(80.8%) 
0 
(0.0%) 
505.5 
(462.5) 
Finland 21 
8 
(38.1%) 
13 
(61.9%) 
0 
(0.0%) 
21 
(100%) 
0 
(0.0%) 
0 
(0.0%) 
21 
(100%) 
0 
(0.0%) 
0 
(0.0%) 
6 
(28.6%) 
15 
(71.4%) 
0 
(0.0%) 
976.0 
(802.0) 
Israel 26 
16 
(61.5%) 
10 
(38.5%) 
0 
(0.0%) 
25 
(96.2%) 
1 
(3.8%) 
0 
(0.0%) 
11 
(42.3%) 
15 
(57.7%) 
0 
(0.0%) 
26 
(100%) 
0 
(0.0%) 
0 
(0.0%) 
1037.0 
(1280.2) 
Italy 489 
87 
(17.8%) 
401 
(82.0%) 
1 
(0.2%) 
275 
(56.2%) 
213 
(43.6%) 
1 
(0.2%) 
449 
(91.8%) 
39 
(8.0%) 
1 
(0.2%) 
42 
(8.6%) 
446 
(91.2%) 
1 
(0.2%) 
404.0 
(572.0) 
Korea 150 
146 
(97.3%) 
4 
(2.7%) 
0 
(0.0%) 
150 
(100%) 
0 
(0.0%) 
0 
(0.0%) 
139 
(92.7%) 
11 
(7.3%) 
0 
(0.0%) 
69 
(46.0%) 
81 
(54.0%) 
0 
(0.0%) 
251.0 
(347.2) 
Latvia 17 
10 
(58.8%) 
7 
(41.2%) 
0 
(0.0%) 
4 
(23.5%) 
13 
(76.5%) 
0 
(0.0%) 
17 
(100%) 
0 
(0.0%) 
0 
(0.0%) 
2 
(11.8%) 
15 
(88.2%) 
0 
(0.0%) 
244.0 
(271.0) 
Malta 2 
2 
(100%) 
0 
(0.0%) 
0 
(0.0%) 
1 
(50.0%) 
1 
(50.0%) 
0 
(0.0%) 
2 
(100%) 
 0 
(0.0%) 
0 
(0.0%) 
1 
(50.0%) 
1 
(50.0%) 
0 
(0.0%) 
1104.0 
(1021.0) 
Norway 50 
7 
(14.0%) 
43 
(86.0%) 
0 
(0.0%) 
6 
(12.0%) 
44 
(88.0%) 
0 
(0.0%) 
47 
(94.0%) 
3  
(6.0%) 
0 
(0.0%) 
5 
(10.0%) 
45 
(90.0%) 
0 
(0.0%) 
278.5 
(284.2) 
Singapore 5 
5 
(100%) 
0 
(0.0%) 
0 
(0.0%) 
5 
(100%) 
0 
(0.0%) 
0 
(0.0%) 
5 
(100%) 
0 
(0.0%) 
0 
(0.0%) 
2 
(40.0%) 
3 
(60.0%) 
0 
(0.0%) 
2773.3 
(815.0) 
Slovenia 10 
10 
(100%) 
0 
(0.0%) 
0 
(0.0%) 
4 
(40.0%) 
6 
(60.0%) 
0 
(0.0%) 
10 
(100%) 
0 
(0.0%) 
0 
(0.0%) 
1 
(10.0%) 
9 
(90.0%) 
0 
(0.0%) 
175.0 
(198.2) 
Sweden 66 
6 
(9.1%) 
59 
(89.4%) 
1 
(1.5%) 
27 
(40.9%) 
38 
(57.6%) 
1 
(1.5%) 
63 
(95.2%) 
1 
(1.5%) 
2 
(3.0%) 
7 
(10.6%) 
58 
(87.9%) 
1 
(1.5%) 
492.5 
(791.5) 
Overall 1163 
431 
(37.1%) 
722 
(62.1%) 
10 
(0.9%) 
588 
(50.6%) 
565 
(48.6%) 
10 
(0.9%) 
1083 
(93.1%) 
69 
(5.9%) 
11 
(0.9%) 
210 
(18.1%) 
943 
(81.1%) 
10 
(0.9%) 
351.0 
(566.0) 
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Table 2. Summary of the multivariate linear regression results 
  Model 1 (all characteristics) Model 2 (restricted characteristics) 
  Coef 95% CI p VIF b Coef 95% CI p VIF b 
High volume of AMI a No (ref) - - - 
1.25 
- - - 
2.87 
 Yes -0.83 (-1.30, -0.36) <0.001 -1.03 (-2.13, 0.06) 0.06 
Catheterization laboratory No (ref) - - - 
1.48 
- - - 
1.55 
 Yes 0.07 (-0.42, 0.56) 0.79 -0.27 (-0.78, 0.24) 0.30 
Academic No (ref) - - - 
1.27 
- - - 
4.01 
 Yes -0.12 (-0.66, 0.42) 0.67 -0.76 (-2.76, 0.96) 0.39 
Urban No (ref) - - - 
1.38 
    
 Yes -0.31 (-0.78, 0.16) 0.20     
Government owned No (ref) - - - 
1.11 
    
 Yes 1.08 (0.31, 1.85) 0.006     
Country : ITA (ref) - - - 
1.05 
- - - 
1.04 
 CAN -0.62 (-1.09, -0.14) 0.01 -0.63 (-1.09, -0.17) 0.007 
 DNK 1.08 (-0.07, 2.23) 0.06 1.10 (-0.03, 2.24) 0.06 
 FIN 3.16 (1.90, 4.43) <0.001 3.38 (2.10, 4.65) <0.001 
 ISR 1.61 (0.32, 2.89) 0.01 0.86 (-0.39, 2.12) 0.18 
 KOR 1.80 (1.14, 2.45) <0.001 1.64 (1.05, 2.23) <0.001 
 LVA 9.30 (7.90, 10.71) <0.001 9.18 (7.79, 10.58) <0.001 
 MLT 9.97 (5.99, 13.95) <0.001 9.81 (5.83, 13.80) <0.001 
 NOR 1.46 (0.60, 2.31) <0.001 1.44 (0.57, 2.31) 0.001 
 SGP 3.51 (0.97, 6.06) 0.007 3.48 (0.94, 6.01) 0.007 
 SVN 2.37 (0.53, 4.20) 0.01 2.15 (0.36, 3.94) 0.02 
 SWE -0.01 (-0.76, 0.73) 0.97 0.01 (-0.73, 0.76) 0.97 
AMI volume*Catheterization     0.55 (-0.69, 1.81) 0.38 3.15 
AMI volume*Academic     -0.17 (-3.38, 3.04) 0.92 5.92 
Catheterization*Academic     1.05 (-0.82, 2.92) 0.27 4.24 
AMI volume*Catheterization*Academic     -0.48 (-3.86, 2.89) 0.78 6.10 
Adjusted R² 0.22 0.22 
a 25% hospitals with the highest AMI volume in each country 
b Variance inflation factors 
CAN: Canada; DNK: Denmark; FIN: Finland; ISR: Israel; ITA: Italy; KOR: South Korea; LVA: Latvia; MLT: Malta; NOR: Norway; SGP: Singapore; 
SVN: Slovenia; SWE: Sweden 
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Table 3. Summary of the within country analyses results (regression coefficients for each within country regression) 
  
High volume 
of AMI (yes) 
Catheterization 
laboratory 
(yes) 
Academic 
(yes) 
AMI volume 
-Catheterization 
(interaction) 
AMI volume 
-Academic 
(interaction) 
Catheterization 
-Academic 
(interaction) 
AMI volume 
-Catheterization 
-Academic 
(interaction) 
Canada -0.74 -1.95 -0.52 2.13 -0.52 1.87 NA 
Denmark -4.64 -1.43 -1.14 4.75 NA NA NA 
Finland -0.80 - -1.15 - NA - - 
Israel -0.84 2.74 - NA - - - 
Italy 2.25 -0.56 -0.30 -2.21 -0.29 0.12 NA 
Korea -3.88** - 0.13 - 1.35 - - 
Latvia -0.61 NA -3.00 NA NA NA NA 
Malta        
Norway -1.69 -2.13 2.01 NA NA NA NA 
Singapore        
Slovenia 1.22 -5.48 3.78 NA NA NA NA 
Sweden -0.10 -0.08 0.16 NA -0.12 NA NA 
Overall -1.33* 0.39 -1.18 0.29 -0.18 1.82 -0.15 
*: p<0.05; **: p<0.01; ***: p<0.001 
Note: regressions could not be run for Malta and Singapore because of the small number of hospitals 
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Table 4. Distribution of the hospitals characteristics, by hospital clusters, and summary of the linear regression results. 
  Cluster 1 
(n=470) 
Cluster 2 
(n=101) 
Cluster 3 
(n=235) 
Cluster 4 
(n=190) 
Cluster 5 
(n=167) 
Academic: Yes 0 (0.0%) 16 (15.8%) 29 (12.3%) 0 (0.0%) 165 (98.8%) 
 No 464 (98.7%) 85 (84.2%) 205 (87.2%) 189 (99.5%) 0 (0.0%) 
Catheterization laboratory: Yes 0 (0.0%) 0 (0.0%) 234 (99.6%) 189 (99.5%) 165 (98.8%) 
 No 464 (98.7%) 101 (100%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Government owned: Yes 452 (96.2%) 100 (99.0%) 234 (99.6%) 146 (76.8%) 151 (90.4%) 
 No 11 (2.3%) 1 (1.0%) 0 (0.0%) 43 (22.6%) 14 (8.4%) 
Urban: Yes 3 (0.6%) 97 (96.0%) 0 (0.00%) 170 (89.5%) 161 (96.4%) 
 No 461 (98.1%) 4 (4.0%) 234 (99.6%) 19 (10.0%) 4 (2.4%) 
AMI volume (median) 197 360 737 399 877 
RSMR (mean) a 9.01 8.79 8.88 9.23 9.43 
Regression coefficient (95% CI) -0.42 (-0.98, 0.15) -0.64 (-1.43, 0.16) -0.55 (-1.19, 0.08) -0.20 (-0.86, 0.47) (ref) 
Regression p-value 0.15 0.12 0.09 0.56 (ref) 
a RSMR were not part of the clusters’ creation and are show for the reader knowledge 
Note: in order to reduce the table size, the “NA” category is not included but remains used for the computation of the percentages 
 
